Capital Wealth Planning Upped Unitedhealth Group (UNH) Position; Sanctuary Wealth Advisors Lowered Exelixis (EXEL) Holding

December 12, 2017 - By wolcottdaily

Capital Wealth Planning Llc increased Unitedhealth Group Inc (UNH) stake by 1847.45% reported in 2017Q2 SEC filing. Capital Wealth Planning Llc acquired 142,993 shares as Unitedhealth Group Inc (UNH)’s stock rose 9.50%. The Capital Wealth Planning Llc holds 150,733 shares with $27.95M value, up from 7,740 last quarter. Unitedhealth Group Inc now has $215.62B valuation. The stock decreased 0.12% or $0.27 during the last trading session, reaching $222.5. About 1.37 million shares traded. UnitedHealth Group Incorporated (NYSE:UNH) has risen 32.76% since December 12, 2016 and is uptrending. It has outperformed by 16.06% the S&P500.

Sanctuary Wealth Advisors Llc decreased Exelixis Inc (EXEL) stake by 99.87% reported in 2017Q2 SEC filing. Sanctuary Wealth Advisors Llc sold 163,908 shares as Exelixis Inc (EXEL)’s stock declined 14.88%. The Sanctuary Wealth Advisors Llc holds 209 shares with $5,000 value, down from 164,117 last quarter. Exelixis Inc now has $7.91B valuation. The stock increased 1.17% or $0.31 during the last trading session, reaching $26.73. About 875,343 shares traded. Exelixis, Inc. (NASDAQ:EXEL) has risen 266.48% since December 12, 2016 and is uptrending. It has outperformed by 249.78% the S&P500.

Among 11 analysts covering Exelixis (NASDAQ:EXEL), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. Exelixis had 34 analyst reports since January 19, 2016 according to SRatingsIntel. The rating was maintained by J.P. Morgan with “Buy” on Friday, July 21. The firm earned “Hold” rating on Monday, June 12 by Oppenheimer. The stock of Exelixis, Inc. (NASDAQ:EXEL) earned “Hold” rating by Oppenheimer on Monday, June 19. The firm earned “Hold” rating on Thursday, August 3 by Deutsche Bank. The company was maintained on Thursday, August 3 by Cowen & Co. The firm has “Hold” rating by Oppenheimer given on Thursday, July 20. SunTrust initiated the shares of EXEL in report on Thursday, July 13 with “Buy” rating. On Monday, April 4 the stock rating was upgraded by Stifel Nicolaus to “Buy”. The firm earned “Buy” rating on Thursday, November 3 by Deutsche Bank. The company was maintained on Monday, July 10 by Oppenheimer.

Investors sentiment decreased to 1.23 in 2017 Q2. Its down 0.10, from 1.33 in 2017Q1. It dived, as 34 investors sold EXEL shares while 64 reduced holdings. 60 funds opened positions while 70 raised stakes. 229.51 million shares or 1.10% less from 232.07 million shares in 2017Q1 were reported. Prudential Fincl has invested 0.02% in Exelixis, Inc. (NASDAQ:EXEL). Ballentine Partners Limited Liability Com reported 16,132 shares stake. Rathbone Brothers Pcl accumulated 0.02% or 20,000 shares. Polar Limited Liability Partnership invested 0.06% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL). Gam Hldg Ag accumulated 51,000 shares or 0.02% of the stock. Royal Commercial Bank Of Canada, a Ontario – Canada-based fund reported 1,683 shares. Qci Asset Mngmt stated it has 0% in Exelixis, Inc. (NASDAQ:EXEL). Parametric Associate Limited Liability holds 0.01% or 354,295 shares. State Of Wisconsin Board holds 57,590 shares or 0% of its portfolio. Paloma Prtn Mgmt Company reported 0.09% stake. Lmr Prtnrs Llp reported 244,963 shares. Old Mutual Glob Investors (Uk) Ltd holds 1.55% or 5.20 million shares in its portfolio. Plancorp Limited Liability Corp has invested 0.09% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL). Us State Bank De has invested 0% in Exelixis, Inc. (NASDAQ:EXEL). Perceptive Advsrs Ltd invested 0.06% of its portfolio in Exelixis, Inc. (NASDAQ:EXEL).

Analysts await Exelixis, Inc. (NASDAQ:EXEL) to report earnings on February, 26. They expect $0.11 earnings per share, down 8.33% or $0.01 from last year’s $0.12 per share. EXEL’s profit will be $32.54 million for 60.75 P/E if the $0.11 EPS becomes a reality. After $0.26 actual earnings per share reported by Exelixis, Inc. for the previous quarter, Wall Street now forecasts -57.69% negative EPS growth.

Investors sentiment decreased to 0.91 in 2017 Q2. Its down 0.11, from 1.02 in 2017Q1. It dropped, as 53 investors sold UNH shares while 496 reduced holdings. 122 funds opened positions while 438 raised stakes. 816.36 million shares or 0.29% more from 813.97 million shares in 2017Q1 were reported. Centre Asset Management Ltd Com has invested 3.7% in UnitedHealth Group Incorporated (NYSE:UNH). Vanguard Gru invested in 64.58 million shares or 0.59% of the stock. The Alabama-based Retirement System Of Alabama has invested 0.7% in UnitedHealth Group Incorporated (NYSE:UNH). Kentucky Retirement System invested in 61,775 shares. Cypress Cap Group Incorporated reported 4,042 shares. Altfest L J & Com holds 0.33% or 2,963 shares in its portfolio. Legal General Group Public Ltd Liability holds 5.09 million shares. Rnc Cap Limited Company reported 1,940 shares. Stock Yards Bank has invested 0.05% in UnitedHealth Group Incorporated (NYSE:UNH). Covington Management reported 1.09% in UnitedHealth Group Incorporated (NYSE:UNH). 9,170 were reported by Ca. 20,312 are owned by Matarin Capital Limited Liability Company. 1,859 are held by Dsc Advsrs L P. Capital Planning Limited Liability stated it has 0.32% in UnitedHealth Group Incorporated (NYSE:UNH). Annex Advisory Llc reported 0.25% stake.

Among 25 analysts covering UnitedHealth Group (NYSE:UNH), 25 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. UnitedHealth Group had 72 analyst reports since September 2, 2015 according to SRatingsIntel. On Saturday, September 23 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by Citigroup with “Buy” on Wednesday, July 19. The firm has “Buy” rating given on Thursday, October 19 by Argus Research. Mizuho upgraded UnitedHealth Group Incorporated (NYSE:UNH) rating on Wednesday, November 30. Mizuho has “Buy” rating and $178 target. The company was maintained on Tuesday, July 18 by Oppenheimer. The stock of UnitedHealth Group Incorporated (NYSE:UNH) has “Buy” rating given on Wednesday, November 29 by Credit Suisse. The firm earned “Outperform” rating on Wednesday, November 30 by RBC Capital Markets. The firm has “Buy” rating by Jefferies given on Wednesday, September 20. The stock of UnitedHealth Group Incorporated (NYSE:UNH) has “Buy” rating given on Tuesday, August 29 by Cantor Fitzgerald. The stock has “Buy” rating by RBC Capital Markets on Monday, June 26.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com